GlassScriptPhysician profile
Thomas Lc Cottrell
NPI 1952666992
$5,381.16
in general payments reported to CMS, 2019-2025
20 companies · $1,403 in 2025
The $1,403 reported for 2025 was more than what 86% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $775 · 2023: $1,461 · 2024: $1,567 · 2025: $1,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,399 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,398.90 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $837.79 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $799.77 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $683.22 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $651.45 | 2023-2025 | |
| Abbvie INC. | $597.96 | 2021-2025 | |
| Exact Sciences Corporation | $334.42 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $276.42 | 2022-2024 | |
| Bausch Health US, LLC | $237.68 | 2023-2025 | Aplenzin, Wellbutrin |
| Ibsa Pharma INC. | $163.34 | 2022-2025 | Tirosint, Tirosint, Licart |
| Abbott Laboratories | $162.15 | 2021 | |
| Corcept Therapeutics | $144.70 | 2024-2025 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $127.99 | 2022 | |
| Amneal Pharmaceuticals LLC | $126.62 | 2022-2025 | Unithroid |
| Axsome Therapeutics, INC. | $58.02 | 2025 | Symbravo |
| Xeris Pharmaceuticals, INC. | $39.09 | 2023 | Keveyis |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $37.10 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.20 | 2024 | Xifaxan, Trulance |
| Rgh Enterprises LLC | $28.57 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.29 | 2022 | |
| Hologic Sales and Service, LLC | $20.38 | 2023 | Thinprep 2000 Processor, Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Cottrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.